Skip to main content
. 2020 May 14;7:74. doi: 10.3389/fcvm.2020.00074

Table 1.

Baseline and procedural characteristics of the present prospective cohort.

Prospective cohort n = 166 IABP-Shock II (score cohort) n = 480 Card-Shock ACS n = 137
Age, mean (SD), years 65 ± 12 70 [58–77] 68 [61–76]
Gender- male, n (%) 137 (82.5) 331 (69) 106 (77)
Height, mean (SD), cm 173 ± 12 174 [167–180] 171 [165–176]
Weight, mean (SD), [kg] 81 ± 17 80 [73–90] 78 [70–85]
BMI, mean (SD), kg/m2 27 ± 4 27 [25-30] 26.8 [24-27]
IABP Shock II Score, median (IQR) 3 [2-4] 3 2
0–2, low-risk, n (%) 72 (43) 235 (49) 81 (59)
3–4, intermediate-risk, n (%) 79 (48) 181 (38) 35 (26)
5–9, high-risk, n (%) 15 (9) 64 (13) 21 (15)
CardShock Score, median (IQR) 5 [4-6]
0–3, low-risk, n (%) 19 (11)
4–5, intermediate-risk, n (%) 72 (44)
6–9, high-risk, n (%) 75 (45)
Admission lactate, mean (SD), mmol/L 6.8 ± 0.5 3.7 [2.1–7.3] 4.3 [1.8–5.2]
Pre-existing conditions
Hypertension, n (%) 100 (60) 341/477 (35) 81 (42)
Diabetes mellitus, n (%) 45 (27) 162/478 (34) 39 (29)
Hyperlipidaemia, n (%) 63 (38) 201/476 (42) 64 (47)
Smoking, n (%) 81 (49) 165/475 (35) 58 (42)
CKD, n (%) 25 (15)
LV-EF, mean (SD), % 21± 10 35
Cardiac arrest prior to Impella, n (%) 65 (39) 209/480 (44) 39 (29)
ROSC, mean (SD), min 20 ± 16
Infarct location, n (%)
 Left main 43 (26) 9%
 LAD 78 (47) 43%
 LCX 17 (10) 17%
 RCA 25 (15) 26%
 Bypass graft 3 (2) 3%
Revascularisation, n (%)
 None 8 (5) 0% 0%
 PCI 156 (94) 100% 100%
 CABG 2 (1) 0% 0%
TIMI flow at the end of procedure
 TIMI 0/I 13 (8)
 TIMI II 15 (9)
 TIMI III 138 (83) 295 (82) 98 (72)
Bridge to durable LVAD 3 (2)

BMI, body mass index; CABG, coronary artery bypass graft; CKD, chronic kidney disease; LAD, left anterior descending coronary artery; LCX, left circumflex coronary artery; LVAD, left ventricular assist device; LV-EF, left-ventricular ejection fraction; PCI, percutaneous coronary intervention; RCA, right coronary artery; ROSC, Return of spontaneous circulation; SAPS II, Simplified Acute Physiology Score-II; TIMI, thrombolysis in myocardial infarction.